Toshiyuki Nishikido
Nabeshima, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Intensive blood pressure-lowering treatment to prevent cardiovascular events in patients with diabetes: a systematic review and meta-analysis.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: December 30, 2024
Clinical potential of inclisiran for patients with a high risk of atherosclerotic cardiovascular disease.
Journal: Cardiovascular diabetology
Published: December 05, 2022
The power of lipid registries for cardiovascular disease prevention.
Journal: Current opinion in lipidology
Published: September 25, 2021
Simple risk-score model for in-hospital major bleeding based on multiple blood variables in patients with acute myocardial infarction.
Journal: International journal of cardiology
Published: September 25, 2021
Serum Albumin and Bleeding Events After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction (from the HAGAKURE-ACS Registry).
Journal: The American journal of cardiology
Published: August 07, 2021
TRS2P and LDL-C alone or in combination for predicting absolute benefits from additional LDL-C lowering: Analysis from the TNT trial.
Journal: Atherosclerosis
Published: December 18, 2020
Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels: One-Year Follow-up of the ORION-1 Randomized Clinical Trial.
Journal: JAMA cardiology
Published: September 26, 2019
GLP-1 analog liraglutide-induced cardiac dysfunction due to energetic starvation in heart failure with non-diabetic dilated cardiomyopathy.
Journal: Cardiovascular diabetology
Published: August 07, 2019
Targeting the peptidase PCSK9 to reduce cardiovascular risk: Implications for basic science and upcoming challenges.
Journal: British journal of pharmacology
Published: February 22, 2019
Non-antibody Approaches to Proprotein Convertase Subtilisin Kexin 9 Inhibition: siRNA, Antisense Oligonucleotides, Adnectins, Vaccination, and New Attempts at Small-Molecule Inhibitors Based on New Discoveries.
Journal: Frontiers in cardiovascular medicine
Published: September 27, 2018
A reduction of BMI predicts the risk of rehospitalization and cardiac death in non-obese patients with heart failure.
Journal: International journal of cardiology
Published: March 27, 2018
Last Updated: 09/26/2026